Pluripotent Stem Cell-Based Cell Therapy—Promise and Challenges

2020/10/01 by Shinya Yamanaka · 9 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Biomedical Ethics and Regulation #CRISPR and Genetic Engineering #Pluripotent Stem Cells Research

paper · pdf · doi:10.1016/j.stem.2020.09.014

crossref issued 2020/10/01 · crossref published 2020/10/01 · crossref published-print 2020/10/01 · openalex publication_date 2020/10/01 · crossref created 2020/10/01 · openalex created_date 2025/10/10 · crossref deposited 2025/10/30 · crossref indexed 2026/07/26 · openalex updated_date 2026/07/29

Cited by

• Fundamental Neurochemistry Review: Incorporating a greater diversity of cell types, including microglia, in brain organoid cultures improves clinical translation
• Stem cell therapies for diabetes
• Chemical reprogramming of human blood cells to pluripotent stem cells
• Human vascularized macrophage-islet organoids to model immune-mediated pancreatic β cell pyroptosis upon viral infection
• Immunophenotypic characterization and clinical relevance of passage number in umbilical cord mesenchymal stromal cells: A review
• Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
• Human stem cells with in vivo high plasticity generated by cell–cell communication
• Functional analysis of cell plasticity using single-cell technologies
• New tissue engineered scaffolds for rotator cuff tendon-bone interface regeneration